SOURCE: Olfactory Biosciences Corp.

October 31, 2013 07:00 ET

Halloween Autism Charity Blitz, OLFC to Donate 20% of All Autism Balm Sales to Autism Charity of Buyer's Choice

In Its Latest Effort to Help Families and Individuals With Autism, OLFC Will Donate 20% of Each Autism Balm Sale to the Autism Charity Determined by the Buyer in the Notes Field of Each Purchase

PHILADELPHIA, PA--(Marketwired - Oct 31, 2013) - Olfactory Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Balm™, is pleased to announce today that they are donating 20% of all NOXO Autism Balm™ sales to the charity of the buyers choice over the next 24 hours. All a buyer needs to do is enter the name of their preferred Autism Charity in the notes field on their order and the charity indicated will receive a donation of 20% of that sale.

OLFC is dedicated to helping as many people as possible that may suffer from the effects of behavioral issues related to sensitivities and overstimulation in children and adults with Autism. NOXO stops the frequency of behavioral issues that trouble individuals with sensitivities by stopping irritant odors and inducing a natural calming effect. Providing protection and relief to the overstimulated person.

Our NOXO brand is currently working with multiple Autism Charities to provide quality information, products and services in order to better assist those affected by Autism. However, on Oct 31, 2013 any Autism Charity can get a donation determined by the purchaser of the NOXO Autism Balm™.

You can get more information on NOXO Autism balm™ at

or on search term: NOXO Autism

About Olfactory Biosciences Corp. (

Olfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples.


"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Contact Information

  • Richard Stevenson
    Olfactory Biosciences Corp.
    333 E. Lancaster Ave. Suite 317
    Wynnewood, PA 19096, USA
    Phone: 484-278-1626